{"References": [{"title": "Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney", "authors": "John W. Funder, Robert M. Carey, Franco Mantero, M. Hassan Murad, Martin Reincke, Hirotaka Shibata, Michael Stowasser, William F. Young", "journal": "Endocrine Reviews", "year": "2016", "volumes": "37", "first page": "189", "last page": "191", "DOI": "10.1210/er.2015-1094"}, {"title": "Mineralocorticoid Receptor Antagonists in the Treatment of Primary Aldosteronism", "authors": "Gian Paolo Rossi, Teresa M. Seccia, Achille C. Pessina", "journal": "Hypertension", "year": "2010", "volumes": "56", "first page": "1006", "last page": "1013", "DOI": "10.1161/HYPERTENSIONAHA.110.158220"}, {"title": "Cardiovascular and Renal Damage in Primary Aldosteronism: Outcomes After Treatment", "authors": "Gian Paolo Rossi, Teresa M. Seccia, Giuseppe Maiolino, Achille C. Pessina", "journal": "American Journal of Hypertension", "year": "2010", "volumes": "23", "first page": "1253", "last page": "1260", "DOI": "10.1038/ajh.2010.169"}, {"title": "Primary Aldosteronism and Cardiovascular Risk, Before and After Treatment", "authors": "Gian Paolo Rossi, Giuseppe Maiolino, Teresa M. Seccia, Achille C. Pessina", "journal": "The Lancet Diabetes & Endocrinology", "year": "2013", "volumes": "1", "first page": "192", "last page": "199", "DOI": "10.1016/S2213-8587(13)70048-X"}, {"title": "The Role of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease", "authors": "Bertram Pitt, Rajiv Agarwal, George L. Bakris, Luis M. Ruilope", "journal": "Kidney International", "year": "2013", "volumes": "84", "first page": "233", "last page": "244", "DOI": "10.1038/ki.2013.147"}, {"title": "Primary Aldosteronism: A Common Cause of Resistant Hypertension", "authors": "Michael Stowasser, Richard D. Gordon", "journal": "CMAJ", "year": "2003", "volumes": "169", "first page": "947", "last page": "953", "DOI": "10.1503/cmaj.1030696"}, {"title": "Mineralocorticoid Receptor Antagonists for Hypertension and Kidney Disease", "authors": "Bertram Pitt, Patrick Rossignol", "journal": "The New England Journal of Medicine", "year": "2019", "volumes": "381", "first page": "2502", "last page": "2514", "DOI": "10.1056/NEJMra1906466"}, {"title": "Primary Aldosteronism: Cardiovascular, Renal and Metabolic Implications", "authors": "Gian Paolo Rossi, Giuseppe Maiolino, Teresa M. Seccia, Achille C. Pessina", "journal": "Trends in Endocrinology & Metabolism", "year": "2008", "volumes": "19", "first page": "88", "last page": "90", "DOI": "10.1016/j.tem.2007.11.003"}, {"title": "The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure", "authors": "Bertram Pitt, Faiez Zannad, Willem J. Remme, Robert Cody, Arthur Castaigne, Alfonso Perez, Jolie Palensky, Joan Wittes", "journal": "The New England Journal of Medicine", "year": "1999", "volumes": "341", "first page": "709", "last page": "717", "DOI": "10.1056/NEJM199909023411001"}, {"title": "Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction", "authors": "Bertram Pitt, Willem Remme, Faiez Zannad, James Neaton, Felipe Martinez, Barbara Roniker, Richard Bittman, Steve Hurley, Jay Kleiman, Marjorie Gatlin", "journal": "The New England Journal of Medicine", "year": "2003", "volumes": "348", "first page": "1309", "last page": "1321", "DOI": "10.1056/NEJMoa030207"}]}